Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry

详细信息    查看全文

• 作者：Asghar Aghamohammadi (1)
  Payam Mohammadinejad (1)
  Hassan Abolhassani (1)
  Babak Mirminachi (1)
  Masoud Movahedi (2)
  Mohammad Gharagozlou (2)
  Nima Parvaneh (1)
  Vaheid Zeiaee (3)
  Bahram Mirsaeed-Ghazi (4)
  Zahra Chavoushzadeh (5)
  Alireza Mahdaviani (5)
  Mahboubeh Mansouri (5)
  Sedigheh Yousefzadegan (1)
  Bahareh Sharifi (1)
  Fariborz Zandieh (4)
  Ehsan Hedayat (1)
  Ali Nadjafi (1)
  Roya Sherkat (6)
  Behzad Shakerian (6)
  Mahnaz Sadeghi-Shabestari (7)
  Reza Farid Hosseini (8)
  Farahzad Jabbari-Azad (8)
  Hamid Ahanchian (8)
  Fatemeh Behmanesh (8)
  Mohammadreza Zandkarimi (8)
  Afshin Shirkani (8)
  Taher Cheraghi (9)
  Abbas Fayezi (10)
  Iraj Mohammadzadeh (11)
  Reza Amin (12)
  Soheila Aleyasin (12)
  Mojgan Moghtaderi (12)
  Javad Ghaffari (13)
  Saba Arshi (14)
  Naser Javahertrash (14)
  Mohammad Nabavi (14)
  Mohammad Hassan Bemanian (14)
  Alireza Shafiei (14)
  Najmedin Kalantari (15)
  Akefeh Ahmadiafshar (16)
  Hossein Ali Khazaei (17)
  Lida Atarod (18)
  Nima Rezaei (1) (19)
  
• 关键词：Epidemiology ; infection ; Iran ; primary immunodeficiency
• 刊名：Journal of Clinical Immunology
• 出版年：2014
• 出版时间：May 2014
• 年：2014
• 卷：34
• 期：4
• 页码：478-490
• 全文大小：
• 参考文献：1. Durandy A, Kracker S, Fischer A. Primary antibody deficiencies. Nat Rev Immunol. 2013;13:519. CrossRef
  2. Durandy A, Taubenheim N, Peron S, Fischer A. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv Immunol. 2007;94:275. CrossRef
  3. Chinen J, Notarangelo LD, Shearer WT. Advances in basic and clinical immunology in 2012. J Allergy Clin Immunol. 2013;131:675. CrossRef
  4. Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131:959. CrossRef
  5. Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127:1329. CrossRef
  6. Aghamohammadi A, Abolhassani H, Mohammadinejad P, Rezaei N. The approach to children with recurrent infections. Iran J Allergy Asthma Immunol. 2012;11:89.
  7. Abolhassani H, Aghamohammadi A, Imanzadeh A, Mohammadinejad P, Sadeghi B, Rezaei N. Malignancy phenotype in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2012;22:133.
  8. Behniafard N, Aghamohammadi A, Abolhassani H, Pourjabbar S, Sabouni F, Rezaei N. Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature. Expert Rev Clin Immunol. 2012;8:155. CrossRef
  9. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54. CrossRef
  10. Parvaneh N, Casanova JL, Notarangelo LD, Conley ME. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol. 2013;131:314. CrossRef
  11. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26:519. CrossRef
  12. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33:1. CrossRef
  13. Rezaei N, Mohammadinejad P, Aghamohammadi A. The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment. Ann N Y Acad Sci. 2011;1238:24. CrossRef
  14. Nourijelyani K, Aghamohammadi A, Salehi Sadaghiani M, Behniafard N, Abolhassani H, Pourjabar S, et al. Physicians awareness on primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2012;11:57.
  15. Al-Herz W, Zainal ME, Salama M, Al-Ateeqi W, Husain K, Abdul-Rasoul M, et al. Primary immunodeficiency disorders: survey of pediatricians in Kuwait. J Clin Immunol. 2008;28:379. CrossRef
  16. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497. CrossRef
  17. Aghamohammadi A, Moein M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. Primary immunodeficiency in Iran: first report of the National Registry of PID in children and adults. J Clin Immunol. 2002;22:375. CrossRef
  18. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190. CrossRef
  19. Srinivasa BT, Alizadehfar R, Desrosiers M, Shuster J, Pai NP, Tsoukas CM. Adult primary immune deficiency: what are we missing? Am J Med. 2012;125:779. CrossRef
  20. Al-Herz W, Zainal ME, Alenezi HM, Husain K, Alshemmari SH. Performance status and deaths among children registered in Kuwait National Primary ImmunoDeficiency Disorders Registry. Asian Pac J Allergy Immunol. 2010;28:141.
  21. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517. CrossRef
  22. Mamishi S, Eghbali AN, Rezaei N, Abolhassani H, Parvaneh N, Aghamohammadi A. A single center 14 years study of infectious complications leading to hospitalization of patients with primary antibody deficiencies. Braz J Infect Dis. 2010;14:351. CrossRef
  23. Litzman J, Stikarovska D, Pikulova Z, Pavlik T, Pesak S, Thon V, et al. Change in referral diagnoses and diagnostic delay in hypogammaglobulinaemic patients during 28 years in a single referral centre. Int Arch Allergy Immunol. 2010;153:95. CrossRef
  24. Garcia JM, Gamboa P, de la Calle A, Hernandez MD, Caballero MT, Garcia BE, et al. Diagnosis and management of immunodeficiencies in adults by allergologists. J Investig Allergol Clin Immunol. 2010;20:185.
  25. Wang LL, Jin YY, Hao YQ, Wang JJ, Yao CM, Wang X, et al. Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004-009). J Clin Immunol. 2011;31:297. CrossRef
  26. Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31:968. CrossRef
  27. Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27:101. CrossRef
  28. CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264-2.
  29. Rhim JW, Kim KH, Kim DS, Kim BS, Kim JS, Kim CH, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci. 2012;27:788. CrossRef
  30. ESID database statistics. In: European Society for Immunodeficiencies. 2013. http://www.esid.org/statistics.php. Accessed 26 Mar 2012
  31. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004-006). J Clin Immunol. 2008;28:186. CrossRef
  32. Al-Tamemi S, Elnour I, Dennison D. Primary immunodeficiency diseases in oman: five years-experience at sultan qaboos university hospital. World Allergy Organ J. 2012;5:52. CrossRef
  33. Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. 2013;33:317. CrossRef
  34. Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2009;29:343. CrossRef
  35. Zadeh N, Getzug T, Grody WW. Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic. Genet Med. 2011;13:263. CrossRef
  36. Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007;27:510. CrossRef
  37. Aghamohammadi A, Moghaddam ZG, Abolhassani H, Hallaji Z, Mortazavi H, Pourhamdi S, et al. Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis. Allergol Immunopathol (Madr). 2013. doi:10.1016/j.aller.2013.02.004 .
  38. Nikfarjam J, Pourpak Z, Shahrabi M, Nikfarjam L, Kouhkan A, Moazeni M, et al. Oral manifestations in selective IgA deficiency. Int J Dent Hyg. 2004;2:19. CrossRef
  39. Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, et al. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol. 2010;30:138. CrossRef
  40. Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, et al. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol. 2009;29:130. CrossRef
  41. Soheili H, Abolhassani H, Arandi N, Khazaei HA, Shahinpour S, Hirbod-Mobarakeh A, et al. Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: from senior idea to novel opportunities. Int Arch Allergy Immunol. 2013;160:208. CrossRef
  42. Aghamohammadi A, Abolhassani H, Biglari M, Abolmaali S, Moazzami K, Tabatabaeiyan M, et al. Analysis of switched memory B cells in patients with IgA deficiency. Int Arch Allergy Immunol. 2011;156:462. CrossRef
  43. Rahiminejad MS, Mirmohammad Sadeghi M, Mohammadinejad P, Sadeghi B, Abolhassani H, Dehghani Firoozabadi MM, et al. Evaluation of humoral immune function in patients with chronic idiopathic thrombocytopenic purpura. Iran J Allergy Asthma Immunol. 2013;12:50.
  44. Rezaei N, Abolhassani H, Aghamohammadi A, Ochs HD. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert Rev Clin Immunol. 2011;7:301. CrossRef
  45. Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, Movahedi M, Parvaneh N, Pouladi N, et al. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol. 2009;19:139.
  46. Aghamohammadi A, Farhoudi A, Nikzad M, Moin M, Pourpak Z, Rezaei N, et al. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Ann Allergy Asthma Immunol. 2004;92:60. CrossRef
  47. Abolhassani H, Sadaghiani MS, Aghamohammadi A, Ochs HD, Rezaei N. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. J Clin Immunol. 2012;32:1180. CrossRef
  48. Aghamohammadi A, Abolhassani H, Moazzami K, Parvaneh N, Rezaei N. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Investig Allergol Clin Immunol. 2010;20:372.
  49. Salek Farrokhi A, Aghamohammadi A, Pourhamdi S, Mohammadinejad P, Abolhassani H, Moazzeni SM. Evaluation of class switch recombination in B lymphocytes of patients with common variable immunodeficiency. J Immunol Methods. 2013;394:94. CrossRef
  50. Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am J Reprod Immunol. 2006;56:145. CrossRef
  51. Rezaei N, Abolhassani H, Kasraian A, Mohammadinejad P, Sadeghi B, Aghamohammadi A. Family study of pediatric patients with primary antibody deficiencies. Iran J Allergy Asthma Immunol. 2013;12:377.
  52. Rivoisy C, Gerard L, Boutboul D, Malphettes M, Fieschi C, Durieu I, et al. Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol. 2012;32:98. CrossRef
  53. Zebracki K, Palermo TM, Hostoffer R, Duff K, Drotar D. Health-related quality of life of children with primary immunodeficiency disease: a comparison study. Ann Allergy Asthma Immunol. 2004;93:557. CrossRef
  54. Abolhassani H, Aghamohammadi A, Abolhassani F, Eftekhar H, Heidarnia M, Rezaei N. Health policy for common variable immunodeficiency: burden of the disease. J Investig Allergol Clin Immunol. 2011;21:454.
  55. Aghamohammadi A, Bahrami A, Mamishi S, Mohammadi B, Abolhassani H, Parvaneh N, et al. Impact of delayed diagnosis in children with primary antibody deficiencies. J Microbiol Immunol Infect. 2011;44:229. CrossRef
  56. Aghamohammadi A, Montazeri A, Abolhassani H, Saroukhani S, Pourjabbar S, Tavassoli M, et al. Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol. 2011;10:47.
  57. Mohammadinejad P, Aghamohammadi A, Abolhassani H, Sadaghiani MS, Abdollahzade S, Sadeghi B, et al. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Investig Allergol Clin Immunol. 2012;22:208.
  58. Vajdic CM, Mao L, van Leeuwen MT, Kirkpatrick P, Grulich AE, Riminton S. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood. 2010;116:1228. CrossRef
  
• 作者单位：Asghar Aghamohammadi (1)
  Payam Mohammadinejad (1)
  Hassan Abolhassani (1)
  Babak Mirminachi (1)
  Masoud Movahedi (2)
  Mohammad Gharagozlou (2)
  Nima Parvaneh (1)
  Vaheid Zeiaee (3)
  Bahram Mirsaeed-Ghazi (4)
  Zahra Chavoushzadeh (5)
  Alireza Mahdaviani (5)
  Mahboubeh Mansouri (5)
  Sedigheh Yousefzadegan (1)
  Bahareh Sharifi (1)
  Fariborz Zandieh (4)
  Ehsan Hedayat (1)
  Ali Nadjafi (1)
  Roya Sherkat (6)
  Behzad Shakerian (6)
  Mahnaz Sadeghi-Shabestari (7)
  Reza Farid Hosseini (8)
  Farahzad Jabbari-Azad (8)
  Hamid Ahanchian (8)
  Fatemeh Behmanesh (8)
  Mohammadreza Zandkarimi (8)
  Afshin Shirkani (8)
  Taher Cheraghi (9)
  Abbas Fayezi (10)
  Iraj Mohammadzadeh (11)
  Reza Amin (12)
  Soheila Aleyasin (12)
  Mojgan Moghtaderi (12)
  Javad Ghaffari (13)
  Saba Arshi (14)
  Naser Javahertrash (14)
  Mohammad Nabavi (14)
  Mohammad Hassan Bemanian (14)
  Alireza Shafiei (14)
  Najmedin Kalantari (15)
  Akefeh Ahmadiafshar (16)
  Hossein Ali Khazaei (17)
  Lida Atarod (18)
  Nima Rezaei (1) (19)
  
  1. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, 62 Qarib St., Keshavarz Blvd., Tehran, 14194, Iran
  2. Department of Allergy and Clinical Immunology, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. Department of Rheumatology, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  4. Department of Immunology, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran
  5. Department of Immunology and Allergy, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. Department of Immunology and Allergy, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  7. Department of Immunology and Allergy, Tabriz University of Medical Sciences, Tabriz, Iran
  8. Department of Immunology and Allergy, Mashhad University of Medical Sciences, Mashhad, Iran
  9. Department of Pediatrics, 17th Shahrivar Children’s Hospital, Guilan University of Medical Sciences, Rasht, Iran
  10. Department of Immunology and Allergy, Ahvaz University of Medical Sciences, Ahvaz, Iran
  11. Department of Immunology and Allergy, Amirkola Hospital, Babol University of Medical Sciences, Babol, Iran
  12. Department of Immunology and Allergy, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
  13. Department of Immunology and Allergy, Mazandaran University of Medical Sciences, Sari, Iran
  14. Department of Immunology and Allergy, Yazd University of Medical Sciences, Yazd, Iran
  15. Department of Immunology and Allergy, Golestan University of Medical Sciences, Gorgan, Iran
  16. Department of Immunology and Allergy, Ghazvin University of Medical Sciences, Ghazvin, Iran
  17. Department of Immunology and Hematology, Zahedan Medical Sciences University, Zahedan, Iran
  18. Department of Pediatrics, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  19. Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  
• ISSN：1573-2592

文摘

Background Primary immunodeficiency disorders (PID) are a group of heterogeneous disorders mainly characterized by severe and recurrent infections and increased susceptibility to malignancies, lymphoproliferative and autoimmune conditions. National registries of PID disorders provide epidemiological data and increase the awareness of medical personnel as well as health care providers. Methods This study presents the demographic data and clinical manifestations of Iranian PID patients who were diagnosed from March 2006 till the March of 2013 and were registered in Iranian PID Registry (IPIDR) after its second report of 2006. Results A total number of 731 new PID patients (455 male and 276 female) from 14 medical centers were enrolled in the current study. Predominantly antibody deficiencies were the most common subcategory of PID (32.3?%) and were followed by combined immunodeficiencies (22.3?%), congenital defects of phagocyte number, function, or both (17.4?%), well-defined syndromes with immunodeficiency (17.2?%), autoinflammatory disorders (5.2?%), diseases of immune dysregulation (2.6?%), defects in innate immunity (1.6?%), and complement deficiencies (1.4?%). Severe combined immunodeficiency was the most common disorder (21.1?%). Other prevalent disorders were common variable immunodeficiency (14.9?%), hyper IgE syndrome (7.7?%), and selective IgA deficiency (7.5?%). Conclusions Registration of Iranian PID patients increased the awareness of medical community of Iran and developed diagnostic and therapeutic techniques across more parts of the country. Further efforts must be taken by increasing the coverage of IPIDR via electronically registration and gradual referral system in order to provide better estimation of PID in Iran and reduce the number of undiagnosed cases.